The efficacy of thermotherapy to treat cutaneous leishmaniasis in Colombia: a comparative observational study in an operational setting

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 103, Issue 7, 2009, Pages 703-706

  Vega, Juan Carlos ^a,b   Sanchez, Boris Fernando ^c   Montero, Luz Mery ^c   Montaña, Rafael ^c   del Pilar Mahecha, Mercedes ^c   Dueñes, Bladimir ^c   Baron, Ángela Rocío ^c   Reithinger, Richard ^d,e  

^a UNIVERSIDAD MILITAR NUEVA GRANADA   (Colombia)

^b UNIVERSIDAD EL BOSQUE   (Colombia)

^c Hospital San Juan Bautista   (Colombia)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Colombia; Leishmaniasis; Meglumine antimoniate; Prevention and control; Thermotherapy; Treatment

Indexed keywords

MEGLUMINE ANTIMONATE;

ADOLESCENT; ADULT; ARTICLE; BODY WEIGHT; CHILD; CLINICAL EFFECTIVENESS; CLINICAL EXAMINATION; CLINICAL TRIAL; COLOMBIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIDEMIC; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; INFANT; INTERMETHOD COMPARISON; LEISHMANIA PANAMENSIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OPEN STUDY; PARASITE IDENTIFICATION; SKIN LEISHMANIASIS;

ADOLESCENT; ADULT; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; COLOMBIA; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INFANT; INFANT, NEWBORN; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67349248616     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2008.10.039     Document Type: Article

References (10)

1. Reithinger R., Dujardin J.C., Louzir H., Pirmez C., Alexander B., and Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis 7 (2007) 581-596
2. Vega J.C., Sanchez B.F., Montero L.M., Montaña R., Del Pilar Mahecha M., Dueñes B., et al. Short communication: the cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004. Trop Med Int Health 12 (2008) 1540-1544
3. Rodríguez-Barraquer I., Góngora R., Prager M., Pacheco R., Montero L.M., Navas A., et al. Etiologic agent of an epidemic of cutaneous leishmaniasis in Tolima, Colombia. Am J Trop Med Hyg 78 (2008) 276-282
4. Reithinger R., Mohsen M., Wahid M., Bismullah M., Quinnell R.J., Davies C.R., et al. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis 40 (2005) 1148-1155
5. Soto-Mancipe J., Grogl M., and Berman J.D. Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia. Clin Infect Dis 16 (1993) 417-425
6. Roussel M., Nacher M., Frémont G., Rotureau B., Clyti E., Sainte-Marie D., et al. Comparison between one and two injections of pentamidine isethionate, at 7 mg/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana. Ann Trop Med Parasitol 100 (2006) 307-314
7. Lai A., Fat E.J., Vrede M.A., Soetosenojo R.M., Lai A., and Fat R.F. Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam. Int J Dermatol 41 (2002) 796-800
8. Navin T.R., Arana B.A., Arana F.E., de Mérida A.M., Castillo A.L., and Pozuelos J.L. Placebo-controlled clinical trial of meglumine antimonate (Glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala. Am J Trop Med Hyg 42 (1990) 43-50
9. Velasco-Castrejon O., Walton B.C., Rivas-Sanchez B., Garcia M.F., Lazaro G.J., Hobart O., et al. Treatment of cutaneous leishmaniasis with localized current field (radio frequency) in Tabasco, Mexico. Am J Trop Med Hyg 57 (1997) 309-312
10. Lobo I.M., Soares M.B., Correia T.M., de Freitas L.A., Oliveira M.I., Nakatani M., et al. Heat therapy for cutaneous leishmaniasis elicits a systemic cytokine response similar to that of antimonial (Glucantime) therapy. Trans R Soc Trop Med Hyg 100 (2006) 642-649